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Abstract
Background Obesity has become a major worldwide public
health issue. There is a need for tools to measure patient-
reported outcomes. The Moorehead–Ardelt Quality of Life
Questionnaire II (MA II) contains six items. The objective
of this study was to translate the MA II into Chinese and
validate it in patients with morbid obesity.
Methods The MA II was translated into Chinese and back-
translated into English by two language specialists to create
the Taiwan version, which was validated by correlations
with two other generic questionnaires of health-related
quality of life (HRQOL), Medical Outcomes Study 36-Item
Short-Form Health Survey (SF-36), and World Health
Organization Quality of Life (WHOQOL)-BREF Taiwan
version. The convergent validity was accomplished by a
series of Spearman rank correlations. Reliability of the MA
II Taiwan version was determined by internal consistency
obtained by Cronbach’s alpha coefficient and test–retest
reliability obtained by intraclass correlation coefficient.
Results One hundred subjects with morbid obesity were
enrolledto test the MA IITaiwan version convergent validity
and internal consistency. Test–retest studies (2 weeks apart)
were applied to 30 morbidly obese patients. Satisfactory
internal consistency was demonstrated by a Cronbach’s
alpha coefficient of 0.79. Good test–retest reliability was
shown by intraclass correlations ranging from 0.73 to 0.91.
The total sum of MA II scores was significantly correlated
with all four domains of the WHOQOL-BREF and two
major components of SF-36 (all correlations, p<0.01; range,
0.44–0.64). All six MA II items showed significant
correlations with each other (r=0.34–0.69, p<0.01), and
the total sum of MA II scores was negatively correlated
with body mass index (r=−0.31, p<0.01), indicating a one-
dimensional questionnaire of HRQOL.
Conclusions The MAIITaiwanversionisanobesity-specific
questionnaire for QOL evaluation with satisfactory reliability
and validity. It has the advantages of extensive evaluation for
HRQOL, cross-cultural application, rapid completion, high
response rates, and an advanced scoring system.
Keywords Morbidobesity.Qualityoflife.Validation.
WHOQOL-BREF.SF-36
Introduction
The prevalence of obesity has increased markedly in the
past 20 years, becoming a major public health issue not
only in the western countries but also in Asia [1–5]. Many
obesity-related comorbidities have been documented [6, 7].
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ces worldwide. Individual quality of life is also significant-
ly influenced by obesity. In general, increases in body mass
index (BMI) are correlated with poorer health-related quality
of life (HRQL) [8]. Many instruments are currently available
to measure the HRQL of subjects with obesity, including the
Medical Outcomes Study 36-Item Short-Form Health Survey
(SF-36) [9–12], the World Health Organization Quality of
Life (WHOQOL) instruments [8], and the Impact of Weight
on Quality of Life (IWQoL) questionnaire [13, 14]. Of the
many methods for treating obesity that have been introduced,
bariatric surgery and behavioral and pharmacologic methods
are reported to be effective based on short-term and/or long-
term weight loss [15–17], decrease in the incidence of
comorbidities, and improvement in patients’ HRQL [9, 18–
20]. To corroborate this evidence, it is crucial to have a
sensitive psychometric tool for detection of obesity-related
impairment of quality of life.
The Moorehead–Ardelt Quality of Life Questionnaire, part
of the Bariatric Analysis and Reporting Outcome System
(BAROS) [21], is a condition-specific instrument for use
with obesity that can be used independently. BAROS has
been utilized in many countries [11, 22–24] and has become
one of the standard outcome evaluations for bariatric surgery.
The original Moorehead–Ardelt Quality of Life Question-
naire was created to measure postoperation outcome. This
questionnaire was improved in 2003 in a second edition
Moorehead–Ardelt Quality of Life Questionnaire II (MA II)
based on suggestions from users [25]. MA II contains six
items (Q1–Q6) and can be applied for both pre-intervention
and postintervention assessments [26].
The WHOQOL group was initiated by the World Health
Organization in 1991 [27, 28]. The WHOQOL is a generic
QOLinstrumentwithtwouniquefeatures.Itassessesphysical,
psychological, social, and environment domains comprehen-
sively. It is also a cross-cultural questionnaire developed for
use across different patient groups located in different
countries [29]. The WHOQOL group later simplified the
standard questionnaire to a short form called WHOQOL-
BREF [30]. This simplified questionnaire is a sensitive tool
for evaluation of HRQOL in patients with various diseases,
including morbid obesity [8, 31–34]. The aims of the present
study were to translate the MA II into Chinese and then cross-
validate it with the Taiwan version of WHOQOL-BREF and
SF-36 among subjects presenting at an obesity clinic.
Methods
Patients
This study was approved by the Institutional Ethics
Committee of E-Da Hospital, I-Shou University. All
patients with morbid obesity who came to the Bariatric
Center before or after surgery during January 2007–July
2008 were invited into this study. Each patient signed an
informed consent form prior to the interview. The surgery
has been regularly performed in this hospital and the
majority received laparoscopic Roux-en-Y gastric bypass
procedure. We adopted the recommendation of the Asia-
Pacific consensus [5], which stipulates that to be eligible for
bariatric surgery, patients must be between age 18 and
65 years and their BMI must fall between 32 and 40 kg/m
2
with obesity related comorbidities, or their BMI must be
more than 40 kg/m
2.
Translation of the Moorehead–Ardelt Quality of Life
Questionnaire II
We obtained the permission of professor Moorehead to
translate and validate the MA II into a Taiwanese version.
The MA II was translated into Chinese and back-translated
into English, respectively, by two specialists familiar with
these two languages to create the Taiwan version. Five
patients with morbid obesity were invited to check the
wording and meanings of the original MA II Taiwan
version. Finally, the MA II Taiwan version was created
after careful discussion in the expert focus group, which
was composed of a dietician, a nurse, and physicians with
five different specialties (namely, psychiatry, obstetrics–
gynecology, surgery, internal medicine, and urology).
Validation of the Moorehead–Ardelt Quality of Life
Questionnaire II
The MA II Taiwan version is the same as the original
questionnaire, which includes six items (Q1: general self-
esteem, Q2: physical activity, Q3: social contacts, Q4:
satisfaction concerning work, Q5: pleasure related to
sexuality, Q6: focus on eating behavior) and specific
color-illustrated graphic symbols to help patients to
understand the items cross-culturally. With this version,
the score of each item is equally weighted and uses a ten-
point Likert scale. The reliability of the MA II Taiwan
version was determined by internal consistency obtained by
Cronbach’s alpha coefficient and the test–retest reliability
was obtained using an intraclass correlation coefficient
(ICC).
The MA II Taiwan version was validated by its
concordance with two other generic health-related quality
of life questionnaires, the Taiwan versions of the SF-36 and
the WHOQOL-BREF. The convergent validity was tested by
a series of Spearman rank correlations among the three
questionnaires. The Taiwan version of the WHOQOL-BREF
contains four domains (physical, psychological, social, and
environment), including the 26 original items of the
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national items for Taiwan. One item addressing “respect
from others” was categorized into the social domain and
another corresponded to “eating what one likes to eat” and
was included in the environment domain. The method of
application, the scoring procedures, and reference time point
(during the last 2 weeks) were the same as for the original
WHOQOL-BREF [28]. The SF-36 Taiwan version is the
first version of SF-36, which contains eight scales (physical
functioning, physical role, bodily pain, general health,
vitality, social function, emotional role, and mental health).
The method of application, the scoring procedures, and the
reference time point (during the last 4 weeks) were the
same as for the original SF-36 [35].
Statistical Analysis
We first conducted a descriptive analysis and listed the
frequencies of the patients’ demographic characteristics.
Internal consistency was indicated by Cronbach’s alpha
coefficient, which was considered useful at a level 0.70.
The test–retest reliability was determined by ICC. An
ICC value of 0.51–0.70 indicated acceptable agreement,
an ICC value of 0.71–0.90 meant good agreement, and
an ICC value greater than 0.90 indicated almost excellent
agreement. Different domains of the WHOQOL-BREF
and different scales of the SF-36 were subsequently
summarized. The total scores for MA II were obtained
by the sum of scores from each item. The convergent
validity was accomplished by a series of Spearman rank
correlations between MA II and the aforementioned two
generic health related QOL questionnaires, WHOQOL-
BREF and SF-36. The test instruments were considered
significant at p<0.01. Multiple linear regression models
were constructed by using the total sum of MA II scores as
the dependent variables, while BMI, age, sex, years of
education, employment, and marital status were included as
the independent predictive variables. A forward stepwise
strategy was applied to select significant independent
variables with p<0.05 as the inclusion criterion. All data
were collected and analyzed using of SPSS Version 12.0.
Results
Demographic Characteristics
One hundred obese patients seen at the E-Da Hospital
Bariatric Center between January 2007 and July 2008 either
before or after surgery were enrolled in this study. Patient
demographics and clinical characteristics are summarized in
Table 1. The mean patient age was 31.0 years and their
mean BMI was 35.6 kg/m
2. The majority (69%) of obese
subjects were women. The proportion of comorbidity with
diabetes mellitus was 13%. No subjects had suffered from
stroke, myocardial infarction, or end stage renal disease
which would significantly impair HRQOL.
Reliability of MA II Taiwan Version
Satisfactory internal consistency was demonstrated by a
Cronbach’s alpha coefficient of 0.79. Good agreement on
test–retest reliability was based on high intraclass corre-
lations: general self-esteem, 0.89 (range, 0.79–0.95);
physical activity, 0.73 (range, 0.51–0.86); social contacts,
0.77 (range, 0.58–0.89); satisfaction concerning work,
0.89 (range, 0.77–0.94); pleasure related to sexuality,
0.91 (range, 0.82–0.96); and focus on eating behavior,
0.81 (range, 0.65–0.91).
Validity of MA II Taiwan Version
The total sums of MA II scores were significantly
correlated with all four domains of the WHOQOL-BREF
and two major components of SF-36 (all correlations,
p<0.01). The WHOQOL-BREF domains were physical
(r=0.48), psychological (r=0.64), social (r=0.58), and
environment (r=0.44). The SF-36 components were phys-
ical health (r=0.49) and mental health (r=0.58). The MA II
scores were also correlated with all eight scales of the SF-36
(all correlations, p<0.01): physical functioning (r=0.48),
physical role (r=0.34), bodily pain (r=0.29), general health
(r=0.53), vitality (r=0.49), social function (r=0.58),
emotional role (r=0.38), and mental health (r=0.45). The
Table 1 Demographic characteristics of patients with obesity enrolled for validation of MA II, Taiwan version
Preoperation (n=50) Postoperation (n=50) Overall (n=100)
Age (mean ± SD, range) 31.6±10.4 (18–59) 30.3±9.2 (19–53) 31.0±9.8
Sex (% female) 66.0 72.0 69.0
Diabetes mellitus (%) 14.0% 12.0% 13.0%
Weight (kg; mean ± SD, range) 109.6±26.8 (80.0–201.0) 90.9±23.6 (57.8–160.6) 99.8±26.7
Height (cm; mean ± SD, range) 167.8±10.6 (150.3–182.8) 166.5±8.3 (150.4–180.8) 167.1±9.4
BMI (kg/m
2; mean ± SD, range) 38.9±9.2 (31.5–69.5) 32.6±6.9 (22.3–50.0) 35.6±8.7
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of MA II scores, WHOQOL-BREF, and SF-36 were similar
in both preoperation and postoperation groups (Table 2).
Matrix of correlation coefficient showed that each individ-
ual item on the MA II Taiwan version had extensive
correlations with the domain scores of WHOQOL-BREF
and dimension scores of SF-36 (Table 3), indicating an
acceptable convergent validity. The fifth item (Q5) focusing
on pleasure related to sexuality had a more significant
correlation with the social and psychological domains of
the WHOQOL-BREF, but less so with the two components
of SF-36. Similarly, the sixth item focusing on eating
behavior was more significantly correlated with the
environmental and social domains of WHOQOL-BREF.
As shown in Fig. 1, the total sum of MA II scores showed a
significant negative correlation with BMI (r=−0.31,
p<0.01). After adjusting for other risk factors, multiple
linear regression models showed that only BMI and
employment were independent variables affecting the total
sum of MA II scores (Table 4).
Discussion
The most important finding from this study is the broad
coverage of QOL concepts by the MA II questionnaire.
With just six questions, it measures all four domains and
two components included in the generic questionnaires
Table 2 Correlation of MA II, WHOQOL-BREF, and SF-36 scores among preoperation and postoperation groups
MA II WHOQOL SF-36
Phy Psy Soc Env PF PR BP GH VT SF ER MH
Pre-OP (n=50) 0.15 11.7* 11.3** 12.7** 13.5** 68.6 49.5 65.6* 39.6** 52.0* 64.5** 53.3 59.2*
Post-OP (n=50) 1.16 12.3** 12.5** 14.3** 13.8** 81.2* 83.3 72.9 67.4* 64.3** 77.0** 85.8 67.3**
Overall (n=100) 0.65 12.0** 11.9** 13.5** 13.6** 77.4** 64.8** 68.6** 52.7** 57.5** 70.0** 67.0** 61.9**
Phy physical, Psy psychological, Soc social, Env environment, PF physical functioning, PR physical role, BP bodily pain, GH general health, VT
vitality, SF social function, ER emotional role, MH mental health, Pre-OP preoperation, Post-OP postoperation
*p<0.05, **p<0.01 (Spearman rank correlation among the total sum of MA II scores, WHOQOL-BREF domain scores, and SF-36 scale scores)
Table 3 Matrix of correlation coefficients among the WHOQOL-BREF, SF-36, and MA II scores
Spearman r
WHOQOL SF-36 MA II
Phy Psy Soc Env PH MH Q1 Q2 Q3 Q4 Q5 Q6
WHOQOL
Phy 1.00 0.65* 0.62* 0.58* 0.07 0.16 0.53* 0.40* 0.43* 0.45* 0.25 0.18
Psy 1.00 0.63* 0.60* 0.25 0.31 0.60* 0.54* 0.64* 0.41* 0.33* 0.33*
Soc 1.00 0.62* 0.42* 0.42* 0.50* 0.49* 0.58* 0.44* 0.39* 0.40*
Env 1.00 0.07 0.23 0.40* 0.31* 0.41* 0.42* 0.30* 0.41*
SF-36
PH 1.00 0.67* 0.42* 0.51* 0.37* 0.27* 0.21 0.28*
MH 1.00 0.57* 0.51* 0.55* 0.38* 0.27* 0.36*
MA II
Q1 1.00 0.69* 0.65* 0.60* 0.45* 0.35*
Q2 1.00 0.62* 0.50* 0.50* 0.42*
Q3 1.00 0.42* 0.53* 0.37*
Q4 1.00 0.38* 0.34*
Q5 1.00 0.42*
Q6 1.00
Phy physical, Psy psychological, Soc social, Env environment, PH physical health, MH mental health
*p<0.01
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correlation matrix presented in Table 3. We also found that
all six items of MA II were significantly correlated with
each other (r=0.34–0.69; p<0.01). With the additional
evidence of significant correlation between the total sum of
MA II and BMI level (Fig. 1), the present study
corroborates the hypothesis that MA II may be a one-
dimensional questionnaire of HRQOL [26]. If we collect
the postoperation group with a longer time after surgery,
such as 1 year, or include the normal population without
obesity, the change of BMIs value could possibly be more
dramatic. Thus, future studies of responsiveness of MA II
had better include subjects with a wider range of BMIs to
corroborate the above prediction. The MA II scoring system
has been changed so that each item was weighted equally
under a ten-point Likert scale. Thus, the total sum of scores
represented the HRQOL of obese patients and would be a
suitable indicator for future cost-effective analyses focused
on controlling obesity.
Although generic instruments, such as WHOQOL-BREF
[8] or SF-36 [9–12], have been proven to be useful for
measuring QOL in an obese population, these surveys have
26 and 36 items, respectively, and generally require a
longer period of time for completion. For comparison, a
review by Duval et al. [36] reported that nine other obesity-
specific quality of life questionnaires contained between
eight and 74 items. For example, the IWQoL questionnaire,
which is probably the most frequently used obesity-specific
QOL questionnaire with good reliability, validity, and
responsiveness, has proven its clinical usefulness in many
studies [13, 14]. However, this survey includes 74 items
and even the IWQoL-Lite has 31 items. On the other hand,
the MA II has only six questions. In our experience, it
could be completed within 1 or 2 min and the response rate
was usually above 95% in clinical application. Moreover,
each question of the MA II has a specific color-illustrated
graphic symbol to assist patients in understanding the
concepts cross-culturally. In this study, we applied the
WHOQOL-BREF and SF-36 in our measurements; both of
which have been demonstrated as excellent cross-cultural
instruments for different patient groups and in different
countries [29, 37–39]. Through cross-validation with the
above two instruments, MA II has demonstrated its
excellent cross-cultural potential.
MA II [26] was modified from the first edition of
Moorehead–Ardelt Quality of Life Questionnaire [21]. The
wording has been changed to be less suggestive so that it
can be utilized with obese subjects either before or after
operation. Moorhead et al. [26] validated the MA II by
testing 110 obese patients before bariatric surgery. In our
study, MA II data were collected from subjects with obesity
both preoperation and postoperation. More than satisfactory
reliabilities were obtained with a Cronbach’s alpha coeffi-
cient of 0.79 and intraclass correlation coefficients between
0.73 and 0.91. The present study also demonstrated good
convergent validity between MA II and SF-36, as well as
MA II and WHOQOL-BREF (Table 2). The MA II scores
were correlated with all eight scales of the SF-36 (all
correlations, p<0.01). However, the American validation
project of the MA II did not correspond to physical
functioning scale of SF-36 [26]. The difference might be
due to the different characteristics of study populations
between our study and the American validation project.
Since we included both preoperation and postoperation
subjects, the ranges of the BMI and QOL values would be
wider, which more likely showed a statistically significant
correlation. Table 2 indicated that the MA II scores had no
Regression coefficient Standard error Partial R square p value
Constant 1.97 0.67
BMI (kg/m
2) −0.05 0.02 0.09 <0.01
Employment 0.59 0.28 0.04 0.04
Table 4 Multiple linear
regression analysis of total
sum of MA II scores in patients
with morbid obesity
Fig. 1 The total sum of MA II scores showed a significant negative
correlation with BMI (r=−0.31, p<0.01)
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SF-36 for the preoperation individuals only, but showed a
significant correlation after we included the postoperation
subgroup. Good MA II construct validity was also validated
by significant correlations with all domains of the
WHOQOL-BREF (p<0.01; Table 2). Therefore, the MA
II was proven to be useful not only with obese patients after
operation but also with patients before intervention.
In conclusion, the MA II Taiwan version is an obesity-
specific questionnaire for QOL evaluation with satisfactory
reliability and validity. It has the advantages of compre-
hensive coverage of four domains of QOL, cross-culture
application, consists of only six items (time-saving) with an
advanced scoring system, and is most likely unidimension-
al. Future demonstration of responsiveness may be useful
for wider clinical application.
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